Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Supportive Care in Cancer
Published in: Supportive Care in Cancer 4/2001

01-06-2001 | Original Article

Use of alternative / complementary therapy in breast cancer patients – a psychological perspective

Authors: Roland Moschèn, Georg Kemmler, Hansjörg Schweigkofler, Bernhard Holzner, Martina Dünser, Rainer Richter, Wolfgang W. Fleischhacker, Barbara Sperner-Unterweger

Published in: Supportive Care in Cancer | Issue 4/2001

Login to get access
Metadata
Title
Use of alternative / complementary therapy in breast cancer patients – a psychological perspective
Authors
Roland Moschèn
Georg Kemmler
Hansjörg Schweigkofler
Bernhard Holzner
Martina Dünser
Rainer Richter
Wolfgang W. Fleischhacker
Barbara Sperner-Unterweger
Publication date
01-06-2001
Publisher
Springer-Verlag
Published in
Supportive Care in Cancer / Issue 4/2001
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s005200000208

Other articles of this Issue 4/2001

Supportive Care in Cancer 4/2001 Go to the issue

Original Article

A randomized, crossover comparison of standard-dose versus low-dose lenograstim in the prophylaxis of post-chemotherapy neutropenia

Original article

Influence of glutamine and glycyl-glutamine on in vitro lymphocyte proliferation in children with solid tumors

Original Article

Oral status during radiotherapy and chemotherapy: a descriptive study of patient experiences and the occurrence of oral complications

Special article

Psychopharmacology in supportive care of cancer: a review for the clinician

Short Communication

Control of irinotecan-induced diarrhea by octreotide after loperamide failure

Review Article

Clinical-practice recommendations for the management of bowel obstruction in patients with end-stage cancer
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits